Jack Henion Joins Cannabis Science and Technology®’s Editorial Advisory Board
Cannabis Science and Technology® is pleased to announce the addition of Jack Henion to its editorial advisory board (EAB).
Dr. Henion is an Emeritus Professor of Toxicology at Cornell University where he participated as a member of the College of Veterinary Medicine commencing in 1976. He co-founded Advion BioSciences in 1993 where he then served as President and CEO until 2006 when he became CSO of Advion, Inc.
Dr. Henion’s research covers a broad landscape, ranging from areas involving gas chromatography–mass spectrometry (GC–MS) and liquid chromatography–tandem mass spectrometry (LC–MS/MS) techniques. His accomplishments don’t end in research, Dr. Henion has received three Doctor Honoris Causa (Honorary Doctorate) degrees in recognition of his international reputation in modern analytical techniques from the University of Ghent, Uppsala University, and Albany University. During his time at Cornell University, Dr. Henion explored the areas of LC–MS utilizing atmospheric pressure ionization (API) sources. He has published 235 peer-reviewed papers in scientific literature, trained around 100 students, post-doctoral scientists, and trainees. All while receiving 12 patents for inventions developed from his research. Through his work, Dr. Henion has received a variety of awards recognizing his efforts to analytical chemistry and entrepreneurship.
In April 2017, Dr. Henion was awarded the Outstanding Contribution to Anti-Doping Science Award from the Partnership for Clean Competition (PCC) for his development of a novel Book-Type Dried Plasma Spot Card. Following suit, Dr. Henion was honored as the winner of the 2018 Bioanalysis Outstanding Contribution Award (BOSCA) in the fall of 2017.
As of December 2019, Dr. Henion retired from Advion, Inc. and is now utilizing his time and knowledge as a consultant on behalf of Henion Enterprises.
For a complete list of the Cannabis Science and Technology® Editorial Advisory Board please visist: www.cannabissciencetech.com/cannabis-science-and-technology-editorial-advisory-board.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
